Central nervous system infections associated with neurologic devices.
Journal
Current opinion in infectious diseases
ISSN: 1473-6527
Titre abrégé: Curr Opin Infect Dis
Pays: United States
ID NLM: 8809878
Informations de publication
Date de publication:
01 06 2021
01 06 2021
Historique:
pubmed:
21
3
2021
medline:
26
8
2021
entrez:
20
3
2021
Statut:
ppublish
Résumé
To review recent data on the epidemiology, microbiology, diagnosis, and management of central nervous system (CNS) infections associated with neurologic devices. The increasing use of implanted neurologic devices has led to an increase in associated infections. Cerebrospinal fluid (CSF) inflammation may be present after a neurosurgical procedure, complicating the diagnosis of CNS infection. Newer biomarkers such as CSF lactate and procalcitonin show promise in differentiating infection from other causes of CSF inflammation. Molecular diagnostic tests including next-generation or metagenomic sequencing may be superior to culture in identifying pathogens causing healthcare-associated ventriculitis and meningitis. Neurologic device infections are serious, often life-threatening complications. Rapid recognition and initiation of antibiotics are critical in decreasing morbidity. Device removal is usually required for cure.
Identifiants
pubmed: 33741795
doi: 10.1097/QCO.0000000000000723
pii: 00001432-202106000-00009
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
238-244Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis 2017; 64:e34–e65.
Hasbun R. Central nervous system device infections. Curr Infect Dis Rep 2016; 18:34doi: 10.1007/s11908-016-0541-x.
doi: 10.1007/s11908-016-0541-x
Dorresteijn KRIS, Jellema K, van de Beek D, Brouwer M. Factors and measures predicting external CSF drain-associated ventriculitis: a review and meta-analysis. Neurology 2019; 93:964–972.
Abulhasan YB, Rachel SP, Châtillon-Angle MO, Alabdulraheem N, et al. Healthcare-associated infections in the neurological intensive care unit: results of a 6-year surveillance study at a major tertiary care center. Am J Infect Control 2018; 46:656–662.
Dorresteijn KRIS, Brouwer MC, Jellema K, van de Beek D. Bacterial external ventricular catheter-associated infection. Expert Rev Antiinfect Therapy 2020; 18:219–229.
Ramanan M, Lipman J, Shorr A, Shankar A. A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections. BMC Infect Dis 2015; 15:3doi: 10.1186/s12879-014-0712-z.
doi: 10.1186/s12879-014-0712-z
Sorinola A, Buki A, Sandor J, Czeiter E. Risk factors of external ventricular drain infection: proposing a model for future studies. Front Neurol 2019; 10:226doi: 10.3389/fneur.2019.00226.
doi: 10.3389/fneur.2019.00226
Hussein K, Rabino G, Feder O, et al. Risk factors for meningitis in neurosurgical patients with cerebrospinal fluid drains: prospective observational cohort study. Acta Neurochirurgica 2019; 161:517–524.
Citerio G, Signorini L, Bronco A, et al. External ventricular and lumbar drain device infections in ICU patients: a prospective multicenter Italian study. Crit Care Med 2015; 43:1630–1637.
Bravo T, Bhimraj A. Hasbun R. Healthcare-acquired meningitis and ventriculitis. Meningitis and encephalitis: management and prevention challenges 1st ed.Switzerland: Springer Nature; 2018. 27–42.
Gibson A, Kaplan SL, Vallejo JS. Impact of serum vancomycin trough levels in the treatment of central nervous system shunt infections caused by coagulase-negative staphylococci. Pediatr Neurosurger 2018; 53:243–246.
McGirt MJ, Zaas A, Fuchs HE, et al. Risk factors for ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 2003; 36:858–862.
Motta F, Antonello CE. Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience. J Neurosurg Pediatr 2014; 13:301–306.
Fjelstad AB, Hommelstad J, Sorteberg A. Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors. J Neurosurg Pediatr 2009; 4:487–493.
Vender JR, Hester S, Waller JL, et al. Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. J Neurosurg 2006; 104: (Suppl): 9–15.
Ghosh D, Mainali G, Khera J, Luciano M. Complications of intrathecal baclofen pumps in children: experience from a tertiary care center. Pediatr Neurosurg 2013; 49:138–144.
Fily F, Haegelen C, Tattevin P, et al. Deep brain stimulation hardware-related infections: a report of 12 cases and review of the literature. Clin Infect Dis 2011; 52:1020–1023.
Bergey GK, Morrell MJ, Mizrahi EM, et al. Long-term treatment with responsive brain stimulation in adults with refractory partial seizures. Neurology 2015; 84:810–817.
Kurtaran B, Kuscu F, Ulu A, et al. The causes of postoperative meningitis: the comparison of gram-negative and gram-positive pathogens. Turk Neurosurg 2018; 28:589–596.
Neuberger A, Shofty B, Bishop B, et al. Risk factors associated with death or neurological deterioration among patients with gram-negative postneurosurgical meningitis. Clin Microbiol Infect 2016; 22:573.e1–573.e4.
Sader E, Moore J, Cervantes-Arslanian AM. Neurosurgical infections. Semin Neurol 2019; 39:507–514.
Chatzopoulos K, Shannon S, Schuetz AN. Clinical utility of anaerobic culture of cerebrospinal fluid. Anaerobe 2020; 64:102246doi: 10.1016/j.anaerobe.2020.102246.
doi: 10.1016/j.anaerobe.2020.102246
Montes K, Jenkinson H, Habib OB, et al. Corrected white blood cell count, cell index, and validation of a clinical model for the diagnosis of healthcare-associated ventriculitis and meningitis in adults with intracranial hemorrhage. Clin Neurol Neurosurg 2019; 178:36–41.
Rogers T, Sok K, Erickson T, et al. Impact of antibiotic therapy in the microbiological yield of healthcare-associated ventriculitis and meningitis. Open Forum Infect Dis 2019; 6:ofz050doi: 10.1093/ofid/ofz050.
doi: 10.1093/ofid/ofz050
Srihawan C, Lopez Castelblanco R, Salazar L, et al. Clinical characteristics and predictors of adverse outcomes in adult and pediatric patients with healthcare-associated ventriculitis and meningitis. Open Forum Infect Dis 2016; 3:ofw077.
Su PY, Miller S, Rutishauser RL, Babik J. Broad-range PCR for early diagnosis of nosocomial Enterococcus gallinarum meningitis. Infect Dis 2016; 48:640–642.
Miller S, Naccache SN, Samayoa E. Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid. Genome Res 2019; 29:831–842.
The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis. Infection in neurosurgery working party of the British Society for Antimicrobial Chemotherapy. Br J Neurosurg 2000; 14:7–12.
Martinez R, Gaul C, Buchfelder M, et al. Serum procalcitonin monitoring for differential diagnosis of ventriculitis in adult intensive care patients. Intensive Care Med 2002; 28:208–210.
Berger C, Schwarz S, Schaebitz WR, et al. Serum procalcitonin in cerebral ventriculitis. Crit Care Med 2002; 30:1778–1781.
Grille P, Verga F, Biestro A. Diagnosis of ventriculostomy-related infection: is cerebrospinal fluid lactate measurement a useful tool? J Clin Neurosci 2017; 45:243–247.
Mrowczynski OD, Langan ST, Rizk EB. Intra-cerebrospinal fluid antibiotics to treat central nervous system infections: a review and update. Clin Neurol Neurosurg 2018; 170:140–158.
Shofty B, Neuberger A, Naffaa ME, et al. Intrathecal or intraventricular therapy for postneurosurgical gram-negative meningitis: matched cohort study, Clin. Microbiol Infect 2016; 22:66–70.
James HE, Walsh JW, Wilson HD, et al. Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery 1980; 7:459–463.
Pelegrin I, Lora-Tamayo J, Gomez-Junyent J, et al. Management of ventriculoperitoneal shunt infections in adults: analysis of risk factors associated with treatment failure. Clin Infect Dis 2017; 64:989–997.
James HE, Walsh JW, Wilson HD, Connor JD. The management of cerebrospinal fluid shunt infections: a clinical experience. Acta Neurochir (Wien) 1981; 59:157–166.
Murthy S, Moradiya Y, Shah J, et al. Incidence, predictors, and outcomes of ventriculostomy-associated infections in spontaneous intracerebral hemorrhage. Neurocrit Care 2016; 24:389–396.
Dawod J, Tager A, Darouiche RO, Mohajer MA. Prevention and management of internal cerebrospinal fluid shunt infections. J Hosp Infect 2016; 93:323–328.
Sheppard JP, Ong V, Lagman C, et al. Systemic antimicrobial prophylaxis and antimicrobial-coated external ventricular drain catheters for preventing ventriculostomy-related infections: a meta-analysis of 5242 cases. Neurosurgery 2020; 86:19–29.
Fried HI, Nathan BR, Rowe AS, et al. The insertion and management of external ventricular drains: an evidence-based consensus statement: a statement for healthcare professionals from the neurocritical care society. Neurocrit Care 2016; 24:61–81.
Whyte C, Alhasani H, Caplan R, Tully AP. Impact of an external ventricular drain bundle and limited duration antibiotic prophylaxis on drain-related infections and antibiotic resistance. Clin Neurol Neurosurg 2020; 190:105641doi: 10.1016/j.clineuro.2019.105641.
doi: 10.1016/j.clineuro.2019.105641
van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med 2010; 362:146–154.